Small molecule · developed by Sunshine Lake Pharma Co.
HEC83518 is an orally taken drug studied in insomnia, with doses given in the morning after an overnight fast in one trial and taken before sleep in another.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04667429 | Phase 1 | Insomnia | Completed | SBFM |
| NCT04596007 | Phase 1 | Insomnia | Completed | SBFM |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Insomnia
Updated Nov 1, 2026. Something wrong or missing? Report it on the SBFM page.
See SBFM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SBFM catalysts and pipeline →